Review of «In Vitro Cell Motility as a Potential Mesenchymal
Stem Cell Marker for Multipotency» from Stem Cells TM by Stuart P. Atkinson
Not exact matches
Previous research shows human induced pluripotent
stem cells (hiPSCs)-- generated directly from adult
cells — can express
markers for a wide variety of
cells, including those that secrete NP.
Three of the four projects receiving CIRM money capitalize on Victoria's expertise at finding
markers for differentiated
stem cells versus
cells that still have tumor - forming potential.
Last December,
for instance, Chien's group reported finding
markers for heart muscle
stem cells by tracing their development from embryonic tissue.
Researchers at Karolinska Institutet have identified
cell surface
markers specific
for the very earliest
stem cells in the human embryo.
«We've not had
cell surface
markers for the different
stem cell states before, which has made it hard to study them,» says Fredrik Lanner, assistant professor at Karolinska Institutet's Department of Clinical Science, Intervention and Technology.
Coxsackie B virus (red) infects
cells positive
for the heart
stem cell marker Sca - 1 (green).
This biomechanical
marker could be used as a rapid and cost - effective approach to enrich
for stem - like
cells in corneal transplant tissue.
«In combination with recent advances in sorting
cells on a biophysical basis, the biomechanical stemness
markers we identified hold the potential to rapidly generate corneal transplants with highly enriched
stem cell populations, which could one day translate into better outcomes
for these patients.»
Expanding from their previous studies with mice, the researchers first established that under specific conditions, culturing human embryonic
stem cells with fibroblast growth factor 2 (FGF2) leads to neural differentiation particular to the midbrain / hindbrain region — the location of the cerebellum — within three weeks, and the expression of
markers for the cerebellar plate neuroepithelium — the part of the developing nervous system specific
for the cerebellum — within five.
For example, labeling of these
cells with
stem - like
cell associated
markers (p63, nestin, and telomerase) have heavily implicated these
cells as
stem cells [13].
However, we have found a fluorescent
marker for nestin, a neural crest
stem cell marker, in the posterior limbal region of the human anterior segment in the vicinity of both the trabecular meshwork and Schwalbe's line (unpublished).
Expression of the Wnt inhibitor Dickkopf - 1 is required
for the induction of neural
markers in mouse embryonic
stem cells differentiating in response to retinoic acid.
Methods: Human corneas with attached scleral rims were obtained from eye banks and were assayed
for telomerase activity and BrdU (bromodeoxyridine) incorporation to determine, respectively, the presence of a
stem - like
cell marker and replicative activity.
Perivascular
cells, including pericytes in the smallest blood vessels (e.g., microvessels) and ARCs around larger ones, express mesenchymal
stem cell markers and bear a multi-differentiation fate potential (differentiate into osteoblasts, chondrocytes, adipocytes, smooth muscle
cells and myocytes) similar to that documented
for MSCs in vitro.
Telomerase activity has been considered to be a
marker for stem cells [23], but it is not found in all
stem cell tissues [24].
Asialoglycoprotein receptor 1 is a specific
cell - surface
marker for isolating hepatocytes derived from human pluripotent
stem cells.
Oct - 4 is a transcription factor which has been reported to be involved in various cancers and is also
marker for cancer
stem cell like population [34, 35].
However, as demonstrated by a recent report from Stuelten and colleagues [13], the complexity of CSC
markers continues to pose challenges
for identifying and isolating the putative tumor
stem cell populations by the
cell - sorting approach.
Support to date
for the existence of an hypoxic niche in marrow blood
stem cells came from indirect evidence such as expression of the hypoxia protein Hif - 1 and related genes and staining with surrogate
markers of hypoxia.
Sophisticated
cell targeting systems such as the gene therapy approach developed
for senescent
cell clearance by Oisin Biotechnologies could also be turned to
stem cell or immune
cell destruction, given suitable
markers of
cell chemistry.
Finally, within the fractionated
cell populations, there was evidence
for coexpression of lineage specific
markers alongside of pluripotency genes, similar to lineage priming described first in hematopoietic
stem cells [15].
She plans to test whether or not molecules designed to target the
marker can block the signaling necessary
for maintaining the
cells»
stem - like properties, which could lead to new antibody - based immunotherapies
for breast cancer.
Oct - 4 is most consistently expressed of the pluripotency genes that we have studied, and it is switched off only in populations that have lost other measurable features of pluripotency, such as
stem cell surface
marker expression and the capacity
for self - renewal.
Immunocytochemical staining
for Ki67 (
cell proliferation
marker), Sox2 (neural
stem cell marker), Olig2 (progenitor
cell marker), and GFAP (glial fibrillary acidic protein, a
marker for differentiated astrocytes) captured by confocal microscopy imaging.
Even more profound was a drop in insulinlike growth factor 1 (IGF - 1), which is a biomarker
for cancer growth, and an increase in
stem cell production, which is a
marker for regeneration of
cells.
Improving
Stem Cell Treatment Success Researchers will manipulate the expression of immune markers on stem cells to develop safer and more effective therapies for horses with musculoskeletal injur
Stem Cell Treatment Success Researchers will manipulate the expression of immune
markers on
stem cells to develop safer and more effective therapies for horses with musculoskeletal injur
stem cells to develop safer and more effective therapies
for horses with musculoskeletal injuries.
Researchers will manipulate the expression of immune
markers on
stem cells to develop safer and more effective therapies
for horses with musculoskeletal injuries.